OK, what do you think would be appropriate at this stage? $, shares, oppies?
There will be a lot of CRs to come, regardless of what they pay themselves. Clinical trials costs $m, the more they progress the more they have to raise. Any pay day will be probably after a successful Ph2, still a few years away. Unless someone wants to buy it out, but again, needs fantastic data to achieve that.
GLTA
IVX Price at posting:
1.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)